PROFILES - Connect with RTRN Researchers

Deepa Bedi
Title Dr
Faculty Rank Assistant Professor
Degree M.D, PhD
Institution Tuskegee University
Department Biomedical Sciences
Clusters Cancer
Obesity and Metabolic Syndromes
307A patterson hall
College of Veterinary Medicine
Tuskegee University
City tuskegee
State AL
Postal Code 36808
Telephone 3347278468
QR Barcode

Narrative icon

Not Available

NIH Awarded Grants icon

  Research projects funded by the National Institutes of Health (NIH), the Centers for Disease Control (CDC), the Food and Drug Administration (FDA), and the Department of Veterans Affairs (VA)

Please wait
2018Phage Display to Identify Epithelial to Mesenchymal Transitioned (EMT) Breast Cancer Cells5SC2CA211028-03
2017Phage Display to Identify Epithelial to Mesenchymal Transitioned (EMT) Breast Cancer Cells5SC2CA211028-02
2016Phage Display to Identify Epithelial to Mesenchymal Transitioned (EMT) Breast Cancer Cells1SC2CA211028-01

Publications icon

  Check NIH Public Access Policy Compliance

Please wait
1. Bedi D, Henderson HJ, Manne U, Samuel T. Camptothecin Induces PD-L1 and Immunomodulatory Cytokines in Colon Cancer Cells. Medicines (Basel). 2019 Apr 24; 6(2).
2. Angajala A, Mothershed E, Davis MB, Tripathi S, He Q, Bedi D, Dean-Colomb W, Yates C. Quadruple Negative Breast Cancers (QNBC) Demonstrate Subtype Consistency among Primary and Recurrent or Metastatic Breast Cancer. Transl Oncol. 2019 Mar; 12(3):493-501.
3. Jones KM, Karanam B, Jones-Triche J, Sandey M, Henderson HJ, Samant RS, Temesgen S, Yates C, Bedi D. Phage Ligands for Identification of Mesenchymal-Like Breast Cancer Cells and Cancer-Associated Fibroblasts. Front Oncol. 2018; 8:625.
4. Henderson HJ, Karanam B, Samant R, Vig K, Singh SR, Yates C, Bedi D. Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival. PLoS One. 2017; 12(12):e0189662.
5. Bedi D, Dennis JC, Morrison EE, Braden TD, Judd RL. Regulation of intracellular trafficking and secretion of adiponectin by myosin II. Biochem Biophys Res Commun. 2017 08 19; 490(2):202-208.
6. Gillespie JW, Gross AL, Puzyrev AT, Bedi D, Petrenko VA. Combinatorial synthesis and screening of cancer cell-specific nanomedicines targeted via phage fusion proteins. Front Microbiol. 2015; 6:628.
7. Bedi D, Gillespie JW, Petrenko VA. Selection of pancreatic cancer cell-binding landscape phages and their use in development of anticancer nanomedicines. Protein Eng Des Sel. 2014 Jul; 27(7):235-43.
8. Bedi D, Gillespie JW, Petrenko VA, Ebner A, Leitner M, Hinterdorfer P, Petrenko VA. Targeted delivery of siRNA into breast cancer cells via phage fusion proteins. Mol Pharm. 2013 Feb 04; 10(2):551-9.
9. Fagbohun OA, Bedi D, Grabchenko NI, Deinnocentes PA, Bird RC, Petrenko VA. Landscape phages and their fusion proteins targeted to breast cancer cells. Protein Eng Des Sel. 2012 Jun; 25(6):271-83.
10. Wang T, Kulkarni N, Bedi D, D''Souza GG, Papahadjopoulos-Sternberg B, Petrenko VA, Torchilin VP. In vitro optimization of liposomal nanocarriers prepared from breast tumor cell specific phage fusion protein. J Drug Target. 2011 Sep; 19(8):597-605.
11. Bedi D, Musacchio T, Fagbohun OA, Gillespie JW, Deinnocentes P, Bird RC, Bookbinder L, Torchilin VP, Petrenko VA. Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes. Nanomedicine. 2011 Jun; 7(3):315-23.
12. Horikawa S, Bedi D, Li S, Shen W, Huang S, Chen IH, Chai Y, Auad ML, Bozack MJ, Barbaree JM, Petrenko VA, Chin BA. Effects of surface functionalization on the surface phage coverage and the subsequent performance of phage-immobilized magnetoelastic biosensors. Biosens Bioelectron. 2011 Jan 15; 26(5):2361-7.
13. Wang T, D''Souza GG, Bedi D, Fagbohun OA, Potturi LP, Papahadjopoulos-Sternberg B, Petrenko VA, Torchilin VP. Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein. Nanomedicine (Lond). 2010 Jun; 5(4):563-74.
14. Jayanna PK, Bedi D, Deinnocentes P, Bird RC, Petrenko VA. Landscape phage ligands for PC3 prostate carcinoma cells. Protein Eng Des Sel. 2010 Jun; 23(6):423-30.
15. Jayanna PK, Bedi D, Gillespie JW, DeInnocentes P, Wang T, Torchilin VP, Bird RC, Petrenko VA. Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency. Nanomedicine. 2010 Aug; 6(4):538-46.
16. Brunson BL, Zhong Q, Clarke KJ, Bedi D, Braden TD, van Santen E, Judd RL. Serum concentrations of adiponectin and characterization of adiponectin protein complexes in dogs. Am J Vet Res. 2007 Jan; 68(1):57-62.
17. Bedi D, Clarke KJ, Dennis JC, Zhong Q, Brunson BL, Morrison EE, Judd RL. Endothelin-1 inhibits adiponectin secretion through a phosphatidylinositol 4,5-bisphosphate/actin-dependent mechanism. Biochem Biophys Res Commun. 2006 Jun 23; 345(1):332-9.
18. Thompson PB, Oldham KT, Bedi DG, Guice KS, Davis M. Aneurysmal malformation of the extrahepatic portal vein. Am J Gastroenterol. 1986 Aug; 81(8):695-7.

Research Resources icon

Publications Timeline

Top MeSH Keywords

Tree Map of Keyword Semantic Groups (Categories)

Left-click a node to move down the tree, right-click the graph to move back up the tree

Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile:
Last Name
See all (3) people See all (60) people Search for (2) people

RTRN Collaboration and Professional Networking Feedback